Kailera Therapeutics, Inc.
No trades
No trades
Compare with Kailera Therapeutics, Inc.
−148.96 M USD
0.00 USD
56.71 M
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Company info
Sector
Industry
CEO
Ronald C. Renaud
Website
Headquarters
Waltham
Founded
2024
IPO date
Apr 17, 2026
IPO offer price
16.00 USD
ISIN
US4829311020
CUSIP
482931102
FIGI
BBG01Q3NQQJ1
Identifiers
ISIN US4829311020
Kailera Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of a broad, advanced, and differentiated portfolio of clinical-stage injectable and oral therapies for the treatment of obesity. Its product candidate includes Ribupatide. The company was founded on May 08, 2024 and is headquartered in Waltham, MA.
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Frequently asked questions
The current price of KLRA is 14.25 USD — it has increased by 0.47% in the past 24 hours. Watch Kailera Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Kailera Therapeutics, Inc. stocks are traded under the ticker KLRA.
KLRA stock has fallen by −6.52% compared to the previous week, the month change is a −21.94% fall, over the last year Kailera Therapeutics, Inc. has showed a −46.23% decrease.
We've gathered analysts' opinions on Kailera Therapeutics, Inc. future price: according to them, KLRA price has a max estimate of 57.00 USD and a min estimate of 30.00 USD. Watch KLRA chart and read a more detailed Kailera Therapeutics, Inc. stock forecast: see what analysts think of Kailera Therapeutics, Inc. and suggest that you do with its stocks.
KLRA reached its all-time high on Apr 20, 2026 with the price of 28.23 USD, and its all-time low was 14.51 USD and was reached on Sep 10, 2026. View more price dynamics on KLRA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
KLRA stock is 9.38% volatile and has beta coefficient of 2.11. Track Kailera Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Kailera Therapeutics, Inc. there?
Today Kailera Therapeutics, Inc. has the market capitalization of 1.93 B, it has decreased by −14.46% over the last week.
Yes, you can track Kailera Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Kailera Therapeutics, Inc. is going to release the next earnings report on Dec 2, 2026. Keep track of upcoming events with our Earnings Calendar.
KLRA earnings for the last quarter are −1.09 USD per share, whereas the estimation was −0.90 USD resulting in a −21.56% surprise. The estimated earnings for the next quarter are −1.06 USD per share. See more details about Kailera Therapeutics, Inc. earnings.
Kailera Therapeutics, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
KLRA net income for the last quarter is −111.31 M USD, while the quarter before that showed −78.86 M USD of net income which accounts for 0.00% change. Track more Kailera Therapeutics, Inc. financial stats to get the full picture.
No, KLRA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 11, 2026, the company has 145 employees. See our rating of the largest employees — is Kailera Therapeutics, Inc. on this list?
Like other stocks, KLRA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Kailera Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.